INSULIN-LIKE GROWTH-FACTOR AXIS ABNORMALITIES IN PROSTATIC STROMAL CELLS FROM PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

被引:103
|
作者
COHEN, P
PEEHL, DM
BAKER, B
LIU, F
HINTZ, RL
ROSENFELD, RG
机构
[1] STANFORD UNIV, MED CTR, DEPT PEDIAT, STANFORD, CA 94305 USA
[2] STANFORD UNIV, MED CTR, DEPT UROL, STANFORD, CA 94305 USA
[3] OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA
来源
关键词
D O I
10.1210/jc.79.5.1410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Benign prostatic hyperplasia (BPH) is a common proliferative disorder of unknown etiology. To assess whether patients with BPH have alterations in their prostatic IGF axis, we measured the expression (by Northern blotting) and the production (by Western ligand blotting and RIA) of insulin-like growth factor-II (IGF-II) and IGF-binding proteins (IGFBPs) in prostatic epithelial and stromal cell strains grown from normal (n = 7), hyperplastic (n = 7), and malignant (n = 5) surgical specimens. Levels of IGF-II messenger ribonucleic acid (mRNA; normalized for actin expression) were 10-fold higher in BPH stromal cell strains compared to those in normal stromal cell strains (P < 0.0001). Western ligand blotting of conditioned medium (CM) from normal stromal cells demonstrated the presence of IGFBP-2, -3, and -4. In the CM of BPH stromal cells, IGFBP-2 levels were dramatically reduced to less than 20% of normal (P < 0.001). Additionally, IGFBP-5, which was not observed in significant amounts in normal stromal cell-CM, was found in large quantities in BPH stromal cell-CM. Northern blot analysis of mRNA from normal and BPH stromal cells demonstrated a 5-fold decrease in IGFBP-2 mRNA (P < 0.001) and a 4-fold increase in IGFBP-5 mRNA (P < 0.01) in BPH compared to normal cells. In prostate stromal cells from cancer specimens, no abnormalities were found. No abnormalities were observed in the IGF axis parameters evaluated in prostate epithelial cells from BPH or cancer strains. We conclude that prostatic stromal cell strains isolated from patients with BPH hyperexpress the mRNA for IGF-II and IGFBP-5 while expressing reduced amounts of IGFBP-2 mRNA. IGFBP, but not IGF-II, peptide levels in CM correspond to the mRNA differences. This is the first documentation of altered gene and protein expression in this common disease. We speculate that these abnormalities in the IGF axis may be important in the pathogenesis of BPH.
引用
收藏
页码:1410 / 1415
页数:6
相关论文
共 50 条
  • [41] PROSTATIC STROMAL INFLAMMATION IS ASSOCIATED WITH LOWER URINARY TRACT SYMPTOM IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    Inamura, So
    Ito, Hideaki
    Shinagawa, Tomochika
    Tsutsumiuchi, Manami
    Taga, Minekatsu
    Kobayashi, Motohiro
    Yokoyama, Osamu
    JOURNAL OF UROLOGY, 2018, 199 (04): : E598 - E598
  • [42] UROGASTRONE EPIDERMAL GROWTH-FACTOR CONCENTRATIONS IN PROSTATIC FLUID OF NORMAL INDIVIDUALS AND PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY
    GREGORY, H
    WILLSHIRE, IR
    KAVANAGH, JP
    BLACKLOCK, NJ
    CHOWDURY, S
    RICHARDS, RC
    CLINICAL SCIENCE, 1986, 70 (04) : 359 - 363
  • [43] Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia
    Sciarra, Alessandro
    Gentile, Vincenzo
    Monti, Salvatori
    Dattilo, Cristian
    Gomez, Anna Autran
    Salciccia, Stefano
    Pannunzi, Laura Proietti
    Toscano, Vincenzo
    Di Silverio, Franco
    UROLOGIA INTERNATIONALIS, 2008, 80 (01) : 68 - 73
  • [44] LOCALIZATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR BY IMMUNOHISTOCHEMICAL METHODS IN HUMAN PROSTATIC-CARCINOMA, PROSTATIC INTRAEPITHELIAL NEOPLASIA, AND BENIGN HYPERPLASIA
    MAYGARDEN, SJ
    STROM, S
    WARE, JL
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1992, 116 (03) : 269 - 273
  • [45] CA repeat polymorphism in the insulin-like growth factor-I (IGF-I) is common risk factor of the metabolic syndrome and the benign prostatic hyperplasia
    Lee, Eunsik
    Yeo, Woongeol
    Park, Kwan Jin
    Jung, Seong Jin
    Byun, Seok-Soo
    JOURNAL OF UROLOGY, 2007, 177 (04): : 445 - 445
  • [46] Letter to the Editor involving in the article "Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia"
    Zhang, Peng
    Su, Xin-Jun
    Hu, Wan-Li
    Wang, Xing-Huan
    AGING MALE, 2018, 21 (03): : 223 - 223
  • [47] INSULIN-LIKE GROWTH FACTOR-II PRODUCTION IN THE PROSTATE - EVIDENCE FOR HYPER-EXPRESSION IN FIBROBLASTS FROM PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY
    COHEN, P
    ROSENFELD, RG
    PEEHL, DM
    HINTZ, RL
    CLINICAL RESEARCH, 1992, 40 (01): : A93 - A93
  • [48] ANDROGEN RECEPTOR ACTIVATION IN PROSTATIC TUMOR-CELL LINES BY INSULIN-LIKE GROWTH FACTOR-L, KERATINOCYTE GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR
    CULIG, Z
    HOBISCH, A
    CRONAUER, MV
    RADMAYR, C
    TRAPMAN, J
    HITTMAIR, A
    BARTSCH, G
    KLOCKER, H
    EUROPEAN UROLOGY, 1995, 27 : 45 - 47
  • [49] ANDROGEN RECEPTOR ACTIVATION IN PROSTATIC TUMOR-CELL LINES BY INSULIN-LIKE GROWTH-FACTOR-I, KERATINOCYTE GROWTH-FACTOR, AND EPIDERMAL GROWTH-FACTOR
    CULIG, Z
    HOBISCH, A
    CRONAUER, MV
    RADMAYR, C
    TRAPMAN, J
    HITTMAIR, A
    BARTSCH, G
    KLOCKER, H
    CANCER RESEARCH, 1994, 54 (20) : 5474 - 5478
  • [50] Intravesical Prostatic Protrusion Is a Risk Factor for Bladder Stone in Patients With Benign Prostatic Hyperplasia
    Kim, Jong Wook
    Oh, Mi Mi
    Park, Hong Seok
    Cheon, Jun
    Lee, Jeong Gu
    Kim, Je Jong
    Moon, Du Geon
    UROLOGY, 2014, 84 (05) : 1026 - 1029